P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
5,752.50
-93.9 (-1.61%)
BSENSE

Dec 05

BSE+NSE Vol: 1.61 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone Annual Results
Jun'24
Jun'23
Jun'22
Jun'21
Jun'20
Dec'18
Dec'17
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Jun 2024 is -6.37% vs 10.34% in Jun 2023

stock-summary

Standalone Net Profit

YoY Growth in year ended Jun 2024 is -12.42% vs 19.19% in Jun 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Jun 2024 is -5.75% vs 21.29% in Jun 2023

stock-summary

Interest

YoY Growth in year ended Jun 2024 is -6.49% vs 83.33% in Jun 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Jun 2024 has improved from Jun 2023

Compare Annual Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,151.26
1,029.99
121.27
11.77%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,151.26
1,029.99
121.27
11.77%
Raw Material Cost
290.23
540.25
-250.02
-46.28%
Purchase of Finished goods
39.46
0.00
39.46
(Increase) / Decrease In Stocks
0.87
-79.02
79.89
101.10%
Employee Cost
215.16
61.00
154.16
252.72%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
299.54
130.03
169.51
130.36%
Total Expenditure (Excl Depreciation)
845.26
652.25
193.01
29.59%
Operating Profit (PBDIT) excl Other Income
306.00
377.74
-71.74
-18.99%
Other Income
15.63
46.26
-30.63
-66.21%
Operating Profit (PBDIT)
321.63
424.00
-102.37
-24.14%
Interest
0.72
0.10
0.62
620.00%
Exceptional Items
-20.19
0.00
-20.19
Gross Profit (PBDT)
300.72
423.90
-123.18
-29.06%
Depreciation
27.40
17.79
9.61
54.02%
Profit Before Tax
273.32
406.10
-132.78
-32.70%
Tax
72.34
100.90
-28.56
-28.31%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
200.98
305.20
-104.22
-34.15%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
200.98
305.20
-104.22
-34.15%
Equity Capital
16.60
34.69
-18.09
-52.15%
Face Value
10.00
2.00
0.00
Reserves
521.64
0.00
521.64
Earnings per share (EPS)
121.07
17.60
103.47
587.90%
Diluted Earnings per share
121.07
17.59
103.48
588.29%
Operating Profit Margin (Excl OI)
26.58%
36.67%
0.00
-10.09%
Gross Profit Margin
26.12%
41.16%
0.00
-15.04%
PAT Margin
17.46%
29.63%
0.00
-12.17%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 1,151.26 Cr
in Jun 2024

Figures in Cr
stock-summary

YoY Growth in year ended Jun 2024 is -6.37% vs 10.34% in Jun 2023

Annual - Standalone Net Profit
Standalone Net Profit 200.98 Cr
in Jun 2024

Figures in Cr
stock-summary

YoY Growth in year ended Jun 2024 is -12.42% vs 19.19% in Jun 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 306.00 Cr
in Jun 2024

Figures in Cr
stock-summary

YoY Growth in year ended Jun 2024 is -5.75% vs 21.29% in Jun 2023

Annual - Interest
Interest 0.72 Cr
in Jun 2024

Figures in Cr
stock-summary

YoY Growth in year ended Jun 2024 is -6.49% vs 83.33% in Jun 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.58%
in Jun 2024

Figures in %
stock-summary

YoY Growth in year ended Jun 2024 has improved from Jun 2023